Cancer patients admitted to the hospital with advanced stages of disease who were referred early to palliative care had decreased health care utilisation and increased use of support services following discharge, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
Published in the Journal of Oncology Practice, the study also determined that a systemised process of referrals resulted in significant improvements in 30-day readmission rates, hospice referral, and receipt of chemotherapy after discharge in patients with advanced cancers.
This is the first study to demonstrate that among advanced cancer patients admitted to an inpatient oncology service, standardised use of triggers for palliative care consultation is associated with substantial improvement on multiple quality measures.
Patients with advanced cancers often have significant symptoms that affect their emotional status, quality of life, and functional ability.
The integration of palliative care improves symptom control and decreases unwanted health care use, yet many patients are never offered these services.
"As cancer progresses, patients are often at high risk for physical pain and emotional distress," said Cardinale B. Smith, MD, MSCR, Associate Professor of Medicine (Hematology and Medical Oncology), and of Geriatrics and Palliative Medicine, at the Icahn School of Medicine at Mount Sinai. "Health care utilisation is extremely high once cancer progresses, with hospital readmission rates as high as 40 percent and death in the acute care setting ranging from 30-50 percent - both measures of poor-quality cancer care."
To improve the quality of care, researchers at the Icahn School of Medicine developed standardised criteria or "triggers" for palliative care consultation for patients admitted to the cancer unit at The Mount Sinai Hospital. Patients were eligible for this prospective cohort study if they met one or more eligibility criteria: advanced solid tumour cancer, prior hospitalisation within 30 days, hospitalisation for more than 7 days, or active symptoms.
"Care for patients with advanced cancer is often characterised by time spent on acute-care hospital wards and intensive care units, or receiving invasive procedures, chemotherapy infusions, and radiographic imaging. Such interventions drive escalating costs and are often directly in conflict with patients' prior stated wishes," said Dr. Smith.
Consultation with the palliative care team included establishment of goals of care, advance care plans using standardised communication protocols, transition planning and symptom assessment and treatment using the Edmonton Symptom Assessment Scale (ESAS).
The palliative team was composed of one board certified PC physician, one nurse practitioner, one social worker, a chaplain, and one to two trainees.
"Our results highlight the need to adopt this practice at acute care hospitals across the nation," said Dr. Smith. "Palliative care involvement helps patients understand their prognosis, establish goals of care, and formulate discharge plans in line with those goals, and this study is the first to confirm the impact of using standardised criteria and automatic palliative care consultation on quality of cancer care."
(27 Mar 2017)